Antares Pharma (ATRS) Misses Q3 EPS by 1c

November 9, 2016 8:04 AM EST
Get Alerts ATRS Hot Sheet
Price: $2.07 +1.97%

Today's EPS Names:
GWPH, KZ, More
Trade ATRS Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Antares Pharma (NASDAQ: ATRS) reported Q3 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $11.15 million.

For earnings history and earnings-related data on Antares Pharma (ATRS) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment